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ABSTRACT
Hypoxia is an imbalance in oxygen delivery and oxygen consumption, ultimately
affecting cell survival. Low levels of oxygen diminish adenosine triphosphate synthesis resulting
from a decline in oxidative phosphorylation in the mitochondria, therefore inducing apoptosis
and cell death. To create a hypoxia mimicked environment, we used hypoxia mimetic
compounds cobalt and nickel to treat human neuroblastoma (NMB) cells. Using hypoxic mimic
human neuronal cell models, we examined and compared the effects of compound-induced
hypoxia on NMB cell proliferation. The cells were treated with 100µM and 300µM
concentrations of each compound at 24- and 48-hour intervals. To investigate cell proliferation,
the thymidine analog EdU was used, which incorporates into DNA during DNA synthesis. Flow
Cytometry was used to measure and analyze the fluorescence of EdU incorporation. Results
showed the inhibition of cell proliferation using both nickel and cobalt treated cells as compared
to the control cells with no treatment. Furthermore, the inhibition of cell proliferation was
dependent upon the exposure time and concentration dose. Interestingly under the same
concentration, cobalt produced greater inhibition of cell proliferation than nickel. Although the
causes of differences are unclear currently, possible reasons are discussed and hypothesized. In
conclusion, this study demonstrated differences in the inhibition of cell proliferation using nickel
or cobalt hypoxic mimetic compounds in human neuronal cells. Further research to determine
mechanisms behind different cell models will provide additional information and understanding
in regard to hypoxia related diseases.
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INTRODUCTION
Oxygen is essential for all eukaryotic survival and is a key element for the production of
adenosine triphosphate (ATP). ATP is the main energy source for biological functions, such as
homeostasis, self-repair and tissue sustenance (Guzy & Schumacker, 2006). To meet the supplydemand of ATP, oxidative phosphorylation utilizes metabolic substrates NADH and NADH2 to
synthesize ATP from ADP and inorganic phosphates. In mitochondria, oxidative
phosphorylation requires oxygen consumption to synthesize ATP. There are several intricate
pathways that allow cells to sense oxygen level fluctuations leading to the development of
adaptations that maintain oxygen tension. When cells encounter insufficient ATP production
with the loss of oxygen, the survival of the cell is threatened. This disadvantage leads to cells
evolving different responses to preserve the required oxygen for survival. Different tissues have
adapted various defense mechanisms under low oxygen conditions known as hypoxia. For
example, arterial chemoreceptors can monitor blood oxygen levels, or cells that secrete
hormones to regulate adequate supply of tissue oxygenation (Guzy & Schumacker, 2006). Upon
hypoxia, some cells have the ability to decrease oxygen utilization, allowing for an increase in
survival rate.
Hypoxia is the condition of low levels of oxygen and is around 3-5% O2 within the
cellular environment (Humar et al., 2002). Pathologically, hypoxia occurs during acute and
chronic vascular disease, pulmonary disease, and cancer, ultimately leading to cell death if
severe and/or prolonged. Further, different tissues require specific amounts of oxygen, when
altered these changes are critical in the pathogenesis of diseases such as stroke, myocardial
infarction and chronic lung disease (Lopez-Barneo et al., 2001). Hypoxia threatens cell survival
because it is a precursor to anoxia; a cellular environment that contains zero oxygen. The
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physiological responses to hypoxia can be categorized as acute or chronic. Chronic hypoxia
responses can take hours, days or even weeks, whereas acute response times are seconds to
minutes. Examples of acute responses are hyperventilation (arterial and airway chemoreceptors),
activation of glucose uptake (cardiac and skeletal muscle, fat tissue), or increase heart output
(peripheral chemoreceptors, heart muscle). Chronic responses occur at the cellular and/or gene
level, such as activation of glucose metabolism and transport, erythropoiesis (bone marrow),
angiogenesis and neovascularization (vascular endothelium, hypoxic or ischemic tissues),
production of vasodilators (vascular endothelium and smooth muscle), and the changes of
various gene expression (Semenza, 2000). Acute responses depend upon excitable cells that have
oxygen sensitive ion channels, allowing for quick responses. Prolonged hypoxia leads to the
changes in gene expression for transporters, enzymes and growth factors that aid against oxygen
deficiency (Humar et al, 2002). Key regulators of transcriptional responses to oxygen deprivation
are proteins known as hypoxia-inducible factors, which sense instabilities in oxygen levels. To
maintain oxygen homeostasis, developmental and physiological pathways are triggered to
upregulate oxygen delivery (Huang et al., 2014).
Ultimately, hypoxia will lead to non-oxidative synthesis of ATP, neovascularization, and
an increase in oxygen carrying capacity of blood. Cellular response to hypoxia leads to the
upregulation of various genes that aid in glucose uptake, glucose metabolism, apoptosis,
glycolysis, glycolytic enzymes, and vascular endothelial growth factor (VEGF) (Humar et al.,
2002; Guzy & Schumacker, 2006; Diguilio et al., 2018). Cellular response is not immediate
because upregulation of genes can include transcription and translation, which requires hours or
days.
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HIF TRANSCRIPTION FACTORS AND ISOFORMS
Hypoxia-inducible factors (HIF) belong to a family of transcription factors, including
HIF-1, HIF-2, and HIF-3, which can regulate several hypoxia response genes. While differential
regulation of the HIF isoforms isn’t completely understood, they all depend upon the
hydroxylation of proline and asparaginyl residues conserved in the N and C termini (Ratcliffe, et
al., 2017). Of the isoforms, HIF-1 and HIF-2 are the most well studied. HIF-1 and HIF-2 have
similar DNA-binding and heterodimerization domains but different sequences in their
transactivating domains, suggesting that they have unique target genes. Studies have suggested
that HIF-1a induces the expression of several glycolytic genes, while HIF-2 is cell-specific and
tissue limited (Hu et al., 2003; Raval et al., 2005; Wigpur et al., 2016). Mole and colleagues
compared HIF-1a and HIF-2a DNA binding discovering many loci bound both HIF-a isoforms,
however, substantially more bound to HIF-1a than HIF-2a. Additionally, further analyses found
distinct patterns of binding occurred for HIF-1a (Mole et al., 2009).
In addition to the transcriptional regulation, the a-subunits of HIF-1 and HIF-2 are
differentially regulated at the transcriptional, translation, and post-translation modification levels.
Although there are overlaps of binding sites between HIF-1 and HIF-2, studies conducted by
Mole et al. showed HIF-2 did not offer transcriptional changes during hypoxic responses but
translational changes in MCF-7 cells. HIF-2 creates a hypoxia-regulated translation initiation
complex between RNA binding protein RBM4 and cap-binding protein eIF4E2. This complex
recruits a wide variety of mRNAs to promote active translation at different polysomes (Wigerup
et al., 2016).
Furthermore, Wigpur and collaborators utilized experimental and clinical data to show
HIFs regulated metastasis and treatment resistance in various tumors. Leading to the hypothesis
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that HIF inhibitor are likely to target important oncogenic processes or pathways. Interestingly,
the two isoforms tend to have contrasting effects on tumor growth, specifically in cell cycle and
apoptotic regulators c-MYC and p53. In summary, HIF-2 and HIF-1 can have opposite effects,
such is the case in essential cell cycle regulator and oncogene, c-Myc. HIF-1a inhibits c-Myc
ultimately suppressing proliferation and leads to c-Myc degradation. Contritely, HIF-2a
enhances c-Myc activity and leads to cell cycle progression in renal carcinoma cells, NIH3T3
cells, HEK293 cells, and embryonic ECs (Wigerup et al., 2016; Gordan et al., 2007). Additional
studies by Holmquist-Mengelbier et al. exhibited HIF-1a under chronic hypoxia degrades over
time, while HIF-2a accumulates continuously in select neuroblastoma cells. This implicated that
HIF-1a mediates quick responses while HIF-2a mediates late responses for hypoxia (HolmquistMengelbier et al., 2006).
Both HIFs are co-expressed in cancers. HIF-1a is primarily active initially under acute
hypoxia, while HIF-2a dominates later under chronic hypoxia, as well as normoxic conditions
(Holmquist-Mengelbier et al., 2006). The most notable difference among the two are tissue
specific differences with few similarities as tumor suppressor proteins in glioblastoma and
teratoma models. Hypoxia inducible factors-1 and 2 overexpression have been associated with
poor clinical outcomes in patients with various cancers. In addition, the HIF-1a protein is
overexpressed in various common solid malignant tumors including breast, colon, gastric, lung,
skin, ovarian, pancreatic, prostate, and renal carcinomas compared to their respective normal
tissues. While the two isoforms have poor prognosis’ when upregulated in cancer, the cancer
type varied. HIF-1a overexpression led to poor survival in cervical cancer, endometrial
carcinoma, oligodendroglioma, ovarian cancer, and different breast cancer subtypes. HIF-2a
overexpression led to poor prognosis in breast cancer, glioblastoma, head and neck squamous

11

carcinoma, and non-small cell lung cancer. Conversely, HIF-1a overexpression showed an
improvement of diagnoses in head and neck cancer, and non-small cell lung cancer (Wigerup et
al., 2016).
Of the HIF isoforms, HIF-1 is well studied. The structure of HIF-1 is a basic helix-loophelix(bHLH)/PAS heterodimeric transcription factor, containing the dimerization of two
subunits, 120-kDa HIF-1a and 91-94kDa HIF-1b (Chanel et al., 1998; Brunelle et al., 2005).
This specific hypoxia-inducible transcription factor is ubiquitously expressed and is an important
factor during hypoxia cellular responses. Of the two subunits, HIF-1a is oxygen-regulated and
required for cellular response to hypoxia. The b subunit is unique to HIF-1, also referred as the
aryl hydrocarbon receptor nuclear translocator or ARNT, is constitutively expressed and has the
ability to dimerize with the arylhydrocarbon receptor (Semenza, 2000). Notably, HIF is regulated
through enzymatic post-translational hydroxylation of the a subunit.
Hypoxia-inducible factor-1a is constitutively transcribed, and translated, but readily
degraded under normoxic conditions. This protein has 826 amino acids with bHLH and PAS
domains located on the N-terminal, which are critical for both dimerization and DNA binding
(Lopez-Barneo et al., 2001). There are two transactivation domains and one protein stability
region located on the C-terminal of HIF-1a. The domain fundamental for stabilization is located
between residues 401 and 603.
After stabilization, HIF-1a translocates to the nucleus, where it dimerizes with HIF-1b.
The transcription factor will bind to the A/GCGTG consensus motif in the promoter regions of
target genes known as hypoxia response elements (HREs) (Wigerup et al., 2016; Urrutia and
Aragones, 2018). When the monomers form the heterodimeric transcription factor, the genes
transcribed will favor tumor aggression, as well as the cell’s survival under hypoxia (Diguilio et
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al., 2018). For HIF-1a stabilization, the a-subunit activates through the detection of low oxygen
levels (around 5% O2), which is sensed within 30 mins. HIF-1a accumulation begins to steadily
increase until it reaches full accumulation near 0.5% O2 roughly 4-8 hours later (Lopez-Barneo
et al., 2001; Jiang et al., 1996; Brunelle et al., 2005).
With the decrease in oxygen tension, HIF-1 binds to HREs on the 3’ flanking region of
the erythropoietin gene, the 5’ flanking region of the VEGF gene and the regulatory elements
encoding glycolytic enzymes (Chanel et al., 1998). There is a HIF-binding region on all the
genes that are hypoxia-sensitive. Hypoxia potentiates HIF-1 activity through HIF-1a
transcriptional activation, mRNA stabilization, nuclear translocation, and the prevention of HIF1a degradation (Semenza, 2000). There are cis-acting DNA sequences that are required and a
trans-acting factor that allows binding to HIF-1 (Wang et al, 1995).
There are multiple factors required for degradation of HIF-1a, including proteins,
enzymes, oxygen, and other cofactors. Prolyl hydroxylases (PHDs) are a family of enzymes with
oxidative properties. PHD’s are tetramers containing 2 hydroxylase units and 2 protein disulfide
isomerase subunits that covalently modify HIF-1a (Harris, 2002). The family includes PHD1,
PHD2, and PHD3. PHDs hydroxylate specific proline residues (Pro402 and Pro564) within the
oxygen-dependent degradation (ODD) domain and facilitate interactions with ubiquitin ligase
(Brunelle et al., 2005). These enzymes require 2-oxoglutarate (a-ketoglutarate), oxygen as
substrates and iron as a cofactor (Guzy & Schumacker, 2006; Urrutia and Aragones, 2018).
Therefore, PHDs sense deviations in the required substrates and cofactors. With a decline in
oxygen tension, PHD ability to hydroxylate is limited due to the restricted oxygen available.
The a subunit’s ability to sense a decline in oxygen tension is due to its ODD domain.
Located within the ODD domain are highly conserved proline residues which are required for
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degradation via the PHD/pVHL pathway. This pathway includes the ubiquitination and
degradation of HIF-1a by prolyl hydroxylases and ubiquitin ligase. PHDs are essential for posttranslational modification signals to properly degrade HIF-1a. Proline hydroxylation modifies
the a subunit required for the von Hippel Lindau (pVHL) tumor suppressor protein to bind to the
modified unit. This protein, also known as the E3 recognition component of the ubiquitin ligase,
is required for ubiquitin labeling and the proteasomal degradation of HIF-1a.
There are stimuli that regulate HIFs such as growth factors, cytokines, hormones, and
other various stressors. Many growth factors have cognate receptors that interact and signal the
phosphoinositide 3-kinase (PI3K) or Ras/MAPK pathways which express HIF. Further, PI3K
pathway inhibition will lead to basal and mitogen-induced HIF inhibition (Wigerup et al., 2016).
Although these non-hypoxia driven stimuli can normalize hypoxic environments, there are
elements that induce hypoxia.
HYPOXIA MIMETICS
Chemical compounds that can stabilize HIF-1a under normoxic conditions are known as
hypoxia mimetics. These compounds artificially induce hypoxia by stabilizing HIF-1a and/or
inhibiting PHD enzymes both directly and indirectly. Further, directly targeting PHDs can lead
to inhibition of activity altogether. Many mimetics will indirectly target PHDs by depleting the
availability of iron, increasing oxygen species production, or creating competition. There are
several compounds commonly used as hypoxia mimetics, such as Cobalt and Nickel.
Cobalt (II) Chloride hexahydrate (CoCl2) is a water-soluble chemical mediator of
hypoxia, also known as, a hypoxic mimetic (Diguilio et al., 2018). Cobalt treatment can increase
the cellular content of HIF-1a through the direct inhibition of prolyl hydroxylases, as well as,
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increasing ROS generation (Chandel et al., 1998). Therefore, cobalt induces gene expression,
specifically RNAs encoding glycolytic enzymes to combat against hypoxia.
Water-soluble and water-insoluble nickel differ in carcinogen potency as well as entrance
into the cell. As a hypoxic mimetic NiCl2 blocks iron uptake, while simultaneously competing
against iron dependent enzymes leading to iron depletion, as well as, HIF-1a stabilization (Costa
et al., 2005). Prolyl hydroxylases are indirectly inhibited due to their dependence upon iron as a
co-factor. This inhibition allows HIF-1a to stabilize, and activate the hypoxia signaling cascade.
HYPOXIA AND CANCER
A tumor microenvironment includes blood and lymphatic vessels, fibroblasts, immune
cells, and an extracellular matrix. Upon progression, cancer cells have limited access to oxygen
and nutrients, causing hypoxic regions. These regions allow for aberrant vascularization which is
related to cancer progression. Cancer cells will undergo genetic and adaptive changes to promote
survival and proliferation under oxidative stress. These adaptions stimulate malignant
phenotypes promoting aggressive tumor behavior. Continual proliferation will lead tumors to
outgrow blood supply, resulting in chronic hypoxia.
Peter Vaupel and colleagues utilized oxygen electrodes to study tumor oxygen supply for
squamous tumors of head and neck, cervical and breast cancers. The results of the study show
low oxygen tension in tumors led to an increase in metastasis, decreasing patient survival in all
cancers studied. There are reports about VHL mutations and HIF-2a upregulation inducing a
hypoxic environment in renal cancer, and cerebellar hemangioblastomas (Harris, 2002).
Additionally, the overexpression of HIF-1a was reported in colon, breast, gastric, lung, skin,
ovarian, pancreatic, prostate and renal carcinomas (Zhong, H. et al, 1999).
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PURPOSE OF EXPERIMENT
Based on the information above, this study examined and compared the effects of
hypoxic mimetic compounds, cobalt and nickel, on NMB cell proliferation using a human
neuroblastoma NMB cell model. The proliferation rates of surviving cells under challenges of
the hypoxic mimic compound at various exposure time and concentrations were investigated. A
hypoxia induced cell model was created using cobalt, nickel, and human neuroblastoma cells. To
measure the cell proliferation, cells were treated with EdU then examined and analyzed with a
flow cytometer.
FLOW CYTOMETRY
The MASQUANT analyzer is a highly sensitive multi-parameter flow cytometer that
utilizes fluidic and optical components for cell analysis. The machine allows for the rapid
analysis of multiple characteristics of different cells supplying both qualitative and quantitative
data. Possible characteristics that can be measured include cell size, cytoplasmic complexity,
DNA or RNA content, and a range of membrane-bound and intracellular proteins (Brown and
Wittwer, 2000).
Forward scatter (FSC) measures physical properties such as size, while side scatter (SSC)
measures the granularity of the cell. Flow cytometry utilizes fluorescent dyes to bind and
intercalate with cellular components, including DNA or RNA. Additionally, antibodies can be
employed to promote the binding of specific proteins and fluorescent dyes.
Flow cytometry utilizes lasers to excite the fluorescent molecules to higher energy states.
When the molecules come down to their resting state, the fluorochromes will emit light energy at
a higher or different wavelength. Using multiple fluorochromes will allow the simultaneous
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measurement of several different cell properties due to the different emission wavelengths. In
this study, fluorescent 488 is the dye used to measure EdU incorporation.
Within the machine, cells are sheathed in an isotonic fluid to create a single cell line or
laminar flow, thus allowing each individual cell to pass through the light emission. Each cell will
pass through a beam of monochromatic light that intersects the cell. The beams then bounce off
in different directions depending on the properties of each cell. Optics collect the lights emitted
into various filters and dichroic mirrors which allow specific wavelengths to be isolated from the
rest (Brown and Wittwer, 2000). These signals can then be detected by photomultiplier tubes
allowing for digitization for computer analysis, via MASQUANT analyzer.
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MATERIALS AND METHODS
CELL CULTURE
Human Neuroblastoma Cells (NMB) were cultured in Roswell Park Memorial Institute (RPMI)
(Invitrogen, Carlsbad, CA, USA), supplemented with 10% Fetal Bovine Serum (FBS) (Atlanta
Biologicals, Flowery Branch, GA, USA) and treated with antibiotics penicillin and gentamicin.
The NMBs were grown in culture flasks at 37°C in 5% CO2 incubator.
TREATMENT
Cells were seeded into six well plates at 7x105 cells concentration per well. Cells were incubated
overnight, harvested and then treated with 100µM and 300µM NiCl2 and CoCl2 concentrations,
separately. Cells were incubated for 24- and 48-hour exposure times. Additionally, each well was
treated with 1µM EdU for 16 hours to track proliferation.
CELL PROLIFERATION ASSAY
The neuroblastoma cells were harvested using PBS EDTA, then centrifuged at 1000 RPMs for
five minutes. Cells resuspended in 1% BSA in PBS then centrifuged and fixed using the click-it
fixative, 4% paraformaldehyde. The NMB cells were centrifuged and resuspended in 1% BSA in
PBS to quench any unreacted fixative. Cells were permeabilized using click-it permeabilization
wash and reagent. EdU buffer additive was added to permeabilized NMB cells to allow for the
detection of EdU under dye fluorescent 488. The fluorescent signals of control and treated cells
were examined using Flow cytometry. Parameters used were: FSC 207V, SSC 322V and B1
316V.
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CLICK- IT REACTION
To detect cell proliferation, cells were incubated with 5-ethynyl-2’-deoxyuridine (EdU) which is
a nucleoside analog of thymidine. EdU directly measures active DNA synthesis of the cell cycle.
It is cell permeable and is incorporated into the DNA during Synthesis (S) phase. Further, EdU is
an easier, faster option that doesn’t require a denaturation step. Click-it chemistry was used to
detect the presence of EdU by a copper-catalyzed covalent reaction between a fluorescent azide
and the alkyne on the EdU molecule. This reaction forms a stable triazole ring, allowing Flow
cytometry to detect and measure the fluorescence of EdU. The fluorescent dyes are required for
measurement because the dyes will intercalate into the helical structure of DNA. This
fluorescence is then directionally proportional to the amount of DNA in the nucleus. Utilizing
this fluorescence to amount for any increase or decrease in DNA, this can show cell proliferation
(increase in DNA) or the inhibition of proliferation (decrease in DNA). Flow results were
analyzed using MASQUANT Analysis and depicted via histograms.
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RESULTS
Cells developing adaptive and/or genetic changes to survive under a low oxygen
environment can lead to tumorigenesis. Therefore, hypoxia is an important element for cancer
research. These adaptations promote malignant phenotypes, ultimately leading to aggressive
tumor behavior (Harris, 2002). Many advanced cancers, such as fibroblasts, neck tumors,
cervical cancer, and soft tissue sarcoma, are known to induce the overexpression of HIF-1a
which is associated with vascularity, and tumor aggression, thus combating hypoxia and
encouraging cell survival (Wigerup et al., 2016).
Nickel and Cobalt are two commonly used hypoxic mimetics. Therefore, we utilized
these compounds to induce a hypoxic environment, then examined and compared how the metals
affected the cell proliferation of surviving neuroblastoma cells under various exposure times and
doses. Cells were then incubated with the thymidine analog EdU which is incorporated into the
DNA during DNA synthesis. Incorporation of EdU was measured and analyzed using flow
cytometry and MASQUANT.
Human NMB neuronal cells were treated with concentrations of 100µM and 300µM of
CoCl2 and NiCl2 to create a hypoxic mimic neuronal cell model. All cells were treated with 1µM
of EdU for 16 hours. Control cells were treated with only EdU. Prior to this study, we conducted
experiments with three different concentrations of EdU at 24- and 48-hour intervals, to find a
concentration without producing cytotoxicity. Of the three concentrations, 1µM EdU yielded the
results we required with minimal cell death.
The graphs are measuring EdU incorporation which occurs during S Phase. The higher
the FITC signal indicates more nucleotide incorporation, suggesting cell proliferation. The large
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second peak is the fluorescence of EdU assimilation into the cells, after DNA synthesis. The first
and smaller peak is indicative of G1 phase. S phase is the dip between the peaks, which is the
area EdU begins incorporation into the DNA. If there is a decrease in EdU incorporation, then
there will be a shift to the left or a decrease in the second peak.
DETERMINATION OF EDU INCORPORATION OF NICKEL TREATMENT
The results of EdU incorporation of cells treated with Nickel for 24 hours are shown in
Figures 1a-c. At 24 hours, Nickel treated cells showed slight inhibition of cell proliferation from
the graph’s shift to the left, best depicted in Figure 2 the overlay of graphs from Figures 1a-c.
Figure 1 shows a slight variation from the control peaks (1a), but there isn’t a significant
difference. Even between the variance in concentrations there isn’t a substantial disparity. For
better understanding, the overlay of Figure 2 shows a clear shift to the left and a dip at 1e1. This
confirms more cells have stayed in G1 phase and have not proceeded through S phase verifying a
decrease in cell proliferation.
Conversely, the higher exposure time shows a significant effect on cellular proliferation.
Figures 3a-c represent EdU incorporation of cells treated with Nickel for 48 hours. There is clear
inhibition of proliferation at the longer exposure time and at the higher concentration seen in
Figure 3c. There is a noteworthy increase in the first peak, and a clear shift to the left. These
distinctions indicate a decrease in cellular proliferation based on EdU incorporation. Again, the
control (3a) shows the second peak is the fluorescence of EdU incorporation. Inhibition is better
depicted in Figure 4, the overlay of graphs from Figures 3a-c. This overlay further confirms the
significance of an exposure time of 48 hours and 300µM concentration. There is a slight shift to
the left at the 24-hour exposure, however, cellular proliferation is clearly stalled at the longer
exposure time. Any shifts to the left or increase in the first peak verify the lack of EdU
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incorporation. No integration means cells are not undergoing synthesis, due to proliferation
inhibition.
DETERMINATION OF EDU INCORPORATION OF COBALT TREATMENT
The results of the cobalt treatments revealed a greater effect on cell proliferation than
nickel. At 24-hour exposure, the cells treated with cobalt shifted immensely as seen in Figures
5a-c. The histograms of Figure 5a and Figure 5b show cells treated with cobalt shifted to the left,
as well as, the first peak increases in size. This clear shift represents cell proliferation inhibition
because EdU is not being incorporated due to cells not transitioning through S phase. Further,
Figure 5c characterizes the stark contrast at the higher concentration of cobalt exposure. Figure 6
illustrates the overlay of the histograms in Figure 5, demonstrating the inhibition in cell
proliferation. The 300µM cobalt treatment is completely void of cells within the second peak.
The lack of the second peak shows that the cells did not transition past S phase, therefore no EdU
was incorporated during synthesis. Although the cells were treated with the same concentration
and exposure times, Cobalt yielded significant results compared to Nickel. Inhibition of cell
proliferation occurred quicker, even at the lower dosages.
The most significant inhibition of proliferation is in Figures 7a-c. These graphs depict
EdU incorporation of cells treated with Cobalt for 48 hours. The histogram of Figure 7c are cells
treated with 300µM of Cobalt for 48 hours, which show a single peak demonstrating that cell
proliferation was indeed inhibited. The treated cells did not transition into S phase but were
completely fixed in G1. Figure 7b yielded a larger difference than the same concentration at a
shorter exposure time (Figure 5b). Further observation of full inhibition is portrayed in the
overlay of Figures 7a-c as shown in Figure 8; all cells shifted to the left and are only in the first
peak confirming no EdU incorporation. For both hypoxic mimetics, the results showed that cell
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inhibition is time and concentration dependent. The longer the exposure time the greater the
inhibition, and correspondingly for a higher concentration of each compound. Of the two metals,
cobalt inhibited proliferation quicker and at a smaller dose, further, the highest inhibition was
seen at the longest exposure time along with the highest dosage.
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a.

c.

b.

Figure 1: 24-hour Nickel Treatment Results
Figure 1a represents the control with no nickel treatment. All controls were treated with only
1µM of EdU for 16 hours. The next two graphs are both 24-hour treatments of NiCl2. Figure 1b
shows the results of cells treated with 100µM NiCl2 and 1µM of EdU. Figure 1c depicts the
results of cells treated with 300µM NiCl2 and 1µM EdU.

Image citation notice: all images included in this thesis are generated by author unless otherwise cited.

24

Figure 2: Overlay of 24-hour Nickel Treatments
The control is represented by black. Pink is the 24-hour 100µM Nickel treatment and blue is the
24-hour 300µM Nickel treatment, all were treated with 1µM EdU for 16 hours. The shift to the
left is indicative of proliferation inhibition due to more cells stuck in the G1 phase (peak one) as
opposed to transitioning through S phase. There is a decrease in the second peak, as further
verification of the decrease in proliferation.
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a.

c.

b.

Figure 3: Results for 48-hour Nickel treatment
Figure 3a is the control, which was only treated with 1µM EdU for 16 hours. Figure 3b is the
results of cells treated at 48 hours with 100µM NiCl2 and 1µM EdU 16-hour treatment. Figure 3c
is the results of the cells treated at 48-hour with 300µM Nickel and 1µM EdU 16-hour treatment,
which shows a clear increase in the first peak. Comparing Figures 3a and 3b,, there is a shift to
the left, as well as an increase in the first peak, which is indicative of a decrease in cellular
proliferation due to cells being stuck in G1 phase. The most significance is seen in 3c. The first
peak has a large increase, as well as a shift to the left. This shows proliferation inhibition because
EdU is not getting incorporated into the cells because they are not passing through S phase.
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Figure 4: Overlay of 48-hour Nickel treatment
Black represents the control which was treated with 1µM EdU for 16 hours. Orange signifies the
cells treated with 100µM Nickel and 1µM EdU at a 48-hour and 16-hour exposure times,
respectively. Green denotes the cells treated with 300µM Nickel and 1µM EdU at a 48- and 16hour intervals, respectively. At 100µM Nickel there is a clear shift to the left, showing more cells
are in the first peak. However, at 300µM Nickel there is a large shift to the left and a large
increase in the first peak because cells are stuck in the G1 phase and the EdU is not being
detected.
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a.

c.

b.

Figure 5: Results of 24-hour Cobalt Treatments
Figure 5a represents the control treated with 1µM EdU for 16 hours. Figure 5b is the 24-hour
100µM Cobalt treatment with 16 hours of 1µM EdU. Lastly, Figure 5c is a 24-hour 300µM
Cobalt treatment with 16 hours of 1µM EdU. The first peak in the 5b shows an increase
compared to the control. While, 5c shows a clear shift to the left and changes in both peaks. Both
are indicative of cell proliferation inhibition because the EdU fluorescence is not being detected,
meaning the cells are not transitioning into S phase.
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Figure 6: Overlay of 24-hour Cobalt Treatments
Black represents our control; the red indicates the 24-hour 100µM Cobalt with 16-hour 1µM
EdU treatment and the purple is the 24-hour 300µM Cobalt with 16-hour 1µM EdU treatment.
Looking at the overlay, there is a clear shift to the left in both concentrations. The 300µM cobalt
treatment shows a greater effect on the neuroblastoma cells than the 100µM and Nickel
treatments. The black line shows where EdU is incorporated, while the purple line shows a
complete lack of the second peak, indicating no cells in that area. This confirms that EdU was
not incorporated into the DNA because the cells never passed through the S phase.
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a.

c.

b.

Figure 7: Results of 48-hour Cobalt Treatments
Figure 7a is the control treated with 1µM EdU for 16 hours. Figure 7b represents the results of
cells treated with 48-hour 100µM cobalt and 16-hour 1µM EdU. Figure 7c depicts the results of
cells treated with 48-hour 300µM cobalt and 16-hour 1µM EdU. The 48-hour 300µM cobalt
treatment only has one peak due to cells being fixed in G1 phase. This peak shows that cell
proliferation was fully inhibited due to a lack of cells transitioning.
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Figure 8: Overlay of 48-hour Cobalt Treatment
The control is signified by black, and blue indicates cells treated at 48 hours with 100µM cobalt
and 16-hour 1µM EdU. Green characterizes the cells treated at 48 hours with 300µM cobalt and
1µM EdU. There is a clear shift to the left for both treated cells. Green shifted more than all
other treatments, showing that 300µM of cobalt yielded the greatest effect on cell proliferation of
neuroblastoma cells. At this exposure time, all cells were prevented from entering S phase.
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DISCUSSION
Hypoxia has no conclusive definition, except that it is a condition where oxygen levels
are below the requirement for cell survival. Scientists and doctors cannot agree on definitive
percentages to claim a tissue or cell is hypoxic due to the varying oxygen levels in diverse tissues
(Hockel and Vaupel, 2001). Conversely, scientists agree understanding the effects of hypoxia on
cells and the human body is important because of the possibilities to discover benefits to help
treat other diseases, such as cancer. Normally, hypoxia leads to a decrease in ATP levels, an
increase in oxygen related stress and ultimately, cell death. In this study, human neuroblastoma
(NMB) cells were treated with hypoxic mimetic compounds CoCl2 and NiCl2 to create a hypoxic
mimetic cell model system. Results showed that nickel and cobalt-induced hypoxic mimic
condition can cause cell death which corroborates the cobalt results from “Human
Neuroblastoma Adaptation to Cobalt Chloride-Induced Hypoxia” (McAuliffe., 2017). However,
there were still surviving cells under these hypoxic mimic conditions. Likely they have
developed the adaptive responses. As compared to the non-treated control cells, these surviving
cells showed a significant decrease in EdU incorporation as the concentrations and exposure time
increased. Although the compounds are similar, the results were significantly incongruent. In
fact, the results from nickel treated cells were not as substantial as the cobalt treatments. Both
mimetics induced a hypoxic environment through the stabilization and accumulation of HIF-1a,
resulting in inhibition of cell proliferation.
In this study, cobalt chloride and nickel chloride were used to induce a hypoxic
environment. Nickel showed slight inhibition of proliferation at all concentrations and exposure,
however, the longest exposure with the highest dose yielded the most significance. In fact, the
24-hour treatments at both concentrations showed trivial variability. Though there was a slight
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shift between Figures 1b and 1c the difference isn’t as significant as the longer exposure time.
The shift can be better analyzed in the overlay shown in Figure 2. Moreover, the 48-hour 100µM
exposure did not show a substantial disparity as displayed in Figures 3a and 3b. The 48-hour
300µM treatment in Figure 3c exhibited significant inhibition with a sizeable increase in the first
peak and a large shift to the left. The overlay of Figure 4 are the graphs from Figures 3a-c, and a
shift for the 100µM treatment can be seen, while the treatment with 300µM shows a decrease in
the second peak and an increase in the first peak. These changes denote inhibition of cell
proliferation at the 48-hour exposure for both 100µM and 300µM nickel treatments because EdU
was not incorporated as seen in the nonexistent second peak. Conversely, cobalt significantly
inhibited cell proliferation at 24-hour 100µM treatment, and amplified inhibition as exposure and
concentration increased.
Cobalt yielded greater influence on cell proliferation than nickel, even at the lowest dose
and least exposure time. At the shortest exposure, cobalt inhibited proliferation more than nickel
at the highest concentration and longest exposure time. The 24-hour 100µM treatment showed a
shift and an increase in the first peak, similar to nickel exposure, as presented in Figure 5b,
compared to the control in Figure 5a. However, the 24-hour 300µM treatment yielded a complete
change, with nearly all the cells shifting out of the second peak as displayed in Figure 5c. The
large variations can be fully analyzed in the overlay of Figure 6, where the complete shift of
Figure 5c confirms inhibition of cell proliferation. As the exposure and concentration increased,
inhibition of proliferation grew greater as well. The 48-hour 100µM treatment shows a severe
increase in the first peak and a large shift to the left. The 100µM concentration at both 24-hour
(Figure 5b) and 48-hour (Figure 7b) yielded increases in the first peak and shifts, however, the
longer exposure produced greater effects. Comparably, the 300µM generated the largest
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inhibition at both exposure times, with highest inhibition at 48-hour as seen in Figure 7c. The
control shows the second peak is 1e2 to 1e3 on the x-axis, this signifies EdU incorporation.
Utilizing this information to further analyze Figure 7c, there is no peak between 1e2 and 1e3, due
to the lack of EdU incorporation. All cells are stuck in G1 phase, concluding full inhibition of
cell proliferation. To fully analyze the effects of cobalt at 48-hour exposure, the overlay in
Figure 8 illuminates the complete shift for 300µM and the large increase of cells stuck in G1 for
100µM.
Cells could not incorporate EdU due to inhibition, preventing the transition into/out of
synthesis phase. Possible explanations could be the mechanism behind hypoxia induction, the
amount of ROS produced or cobalt toxicity. Littman et al. conducted a study to examine
chondrogenesis and compare cobalt induced hypoxia with a cellular environment living in low
oxygen levels in human mesenchymal stem cells treated for 24 hours, 4 days and 7 days. From
their results, cobalt treated cells resulted in cell death more than cells treated within a hypoxic
environment. They theorized cobalt may induce apoptosis pathways, resulting in higher levels of
cell death. Comparing these results to the results in this study, cobalt may inhibit cell
proliferation more than Nickel because it induces pathways leading to cell death. Further
hypothesis includes the different mechanism of prolyl hydroxylase inhibition. Cobalt directly
inhibits PHDs, while nickel indirectly inhibits PHDs through blocking iron uptake, and
competing against iron dependent enzymes (Chandel et al., 1998; Costa et al., 2005). Comparing
and examining the difference between direct and indirect inhibition may further aid in
understanding key differences of cobalt and nickel as hypoxic mimetics.
Both metals belong to group VII in the periodic chart, confirming similar chemical
properties. Further, each compound produces reactive oxygen species and allows for the
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accumulation of HIF-1a. Long term exposure to NiCl2 as well as CoCl2 has shown detrimental
effects on the human body (Yao et al., 2014). Extensive exposure to NiCl2 will lead to an
accumulation of nickel intracellularly. In a study conducted by Costa et al., at 24 hours of
exposure nickel ions reside in the cytoplasm, however, when increased to 72 hours, the ions
translocate to the nucleus. In the same study, Cobalt is proven to have harsh consequences on
embryonic stem cells. Nickel compounds are water-insoluble and water-soluble. The waterinsoluble nickel are readily phagocytized while the water-soluble diffuses through the cell
membrane (NTP Toxicology and Carcinogenesis Studies of Ni Sulfate Hexahydrate, 1996).
Combining the results from previous studies, we hypothesized that the translocation of nickel
will increase the harmful effects on the cell, including cell proliferation. This hypothesis was
proven correct when we saw inhibition of proliferation due to prolonged NiCl2 exposure.
Due to the severity and possible detrimental effects, cells have adapted defense
mechanisms to fight hypoxia and alleviate oxygen tension. As described by Hockel and Vaupel,
pathological causes of hypoxia include low oxygen partial pressure/oxygen tension in arterial
blood due to pulmonary diseases or high altitudes (hypoxemic hypoxia), reduced ability of blood
to carry oxygen, reduced tissue perfusion, deterioration of the diffusion of geometry and inability
of cells to use oxygen due to intoxication caused from poisoning. While the underlying
mechanism behind sensing oxygen change is not wholly understood, a family of proteins known
as hypoxia inducible factors has an oxygen sensitive subunit to mediate hypoxia. Most notably,
HIF-1a is oxygen sensitive, however, it is also important for tumor microenvironment (Diguilio
et al., 2018).
Hypoxia-regulated pathways that overlap with oncogenic signaling pathways include
cellular proliferation, angiogenesis, metabolism, apoptosis, immortalization, and migration
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(Harris, 2002). Further, cellular proliferation induces growth factors that promote cellular
proliferation, migration, and regeneration, as well as, transforms growth factor-b and plateletderived growth factor glioblastoma. Hypoxia induced angiogenesis via growth factors, such as
VEGF, can be blocked by inhibitors of oncogene signaling pathways. The tumor
microenvironment includes blood vessels, lymphatic vessels, fibroblasts, immune cells and
chemicophysical components which leads to restricted oxygen and nutrients. This limited access
leads to hypoxic regions which allows for aberrant vascularization which is considered a feature
of cancer and promotes cancer progression. Further, hypoxia induces differentiation of nonspecific CD4+ T cells into regulatory T cells or T helpers (Petrova et al., 2018). Additionally,
Gatenby and colleagues used oxygen electrodes to study tumor oxygen supply; their results
showed low oxygen tension in tumors lead to an increase in metastasis and poor survival in
patients for squamous tumors of head and neck, cervical and breast cancer.
Under hypoxia, cells switch from glucose metabolism and oxygen-dependent
tricarboxylic acid to glycolysis, the oxygen-independent metabolic pathway. Kim et al. provided
the first evidence that HIF-1 actively participates in metabolic reprogramming from the TCA
cycle to glycolysis by showing that HIF-1 directly targets the gene encoding pyruvate
dehydrogenase kinase 1 (PDK1). This led to the inactivation of pyruvate dehydrogenase (PDH),
which catalyzes pyruvate into acetyl-CoA. Cancer cells can utilize glycolysis as its primary
mechanism of ATP production. The utilization of glycolysis instead of the TCA cycle permits
cancer cells to consume less energy. Further, studies show that telomerase increases when cancer
cells are within a hypoxic environment, which leads to cellular immortalization (Harris, 2002).
From the analysis of our results, we conclude that the inhibition of cell proliferation is
dose-dependent and time-dependent. Paralleling the compounds, we conclude cobalt has a
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greater effect on cell proliferation than nickel. For future studies, we can further compare other
hypoxic mimetic compounds, such as desferrioxamine (DFO), and its effects on cell
proliferation. More experimental analysis can lead to a better understanding of the mechanisms
behind cobalt and nickel induced hypoxia, as well as, future possibilities of utilizing these
understandings to treat cancer.
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